South Korean private equity house Korea Corporate Governance Improvement’s Managing Partner Lim Hyun-chol said the performance of activist funds should not be judged by the time frame of their investments. “The significance lies not in the length of the investment period but rather in the actual changes brought about in the company after the activist fund's calls,” Lim said during a recent inte.
Korea's family-owned conglomerates have enjoyed their privileges for decades. That may be set to end. Lee Jae-Young was halfway through a five-year jail sentence for fraud, embezzlement and bribing Korea's then-president when he was granted a special presidential pardon in August 2022. Lee, heir to the multi-billion dollar Samsung corporation and a former chief executive, [.] The post Korea's chaebol set to enter the twilight zone? appeared first on 360.
The Korea Corporate Governance Improvement (KCGI) has decided to sell its 6.92 percent stake in Osstem Implant during a tender offer launched late last month by a consortium made up of Unison Capital Korea and MBK Partners, according to the activist fund. The tender offer is scheduled to last through Feb. 24.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.